{
    "clinical_study": {
        "@rank": "107902", 
        "arm_group": [
            {
                "arm_group_label": "2 to 5 years  (FPV/RTV)", 
                "arm_group_type": "Experimental", 
                "description": "Two to five years. Fosamprenavir (FPV) 700 mg tablets or 50 mg/mL oral suspension/ritonavir (RTV) 100 mg capsules or 80 mg/mL oral solution once daily (QD)"
            }, 
            {
                "arm_group_label": "6 to 11 years (FPV/RTV)", 
                "arm_group_type": "Experimental", 
                "description": "Six to twelve years. Fosamprenavir (FPV) 700 mg tablets or 50 mg/mL oral suspension/ritonavir (RTV) 100 mg capsules or 80 mg/mL oral solution once daily (QD)"
            }, 
            {
                "arm_group_label": "12 to 18 years (FPV/RTV)", 
                "arm_group_type": "Experimental", 
                "description": "Twelve to Eighteen years. Fosamprenavir (FPV) 700 mg tablets or 50 mg/mL oral suspension/ritonavir (RTV) 100 mg capsules or 80 mg/mL oral solution once daily (QD)"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a 48-week study to collect additional information on the safety, tolerability,\n      pharmacokinetics, and antiviral activity of an investigational regimen (course of therapy)\n      including FDA approved HIV drugs in HIV-infected patients 2 - 18 years old."
        }, 
        "brief_title": "A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": {
                        "@group_id": "B1", 
                        "description": "Fosamprenavir (FPV) 700 mg tablets or 50 mg/mL oral suspension/ritonavir (RTV) 100 mg capsules or 80 mg/mL oral solution once daily (QD)", 
                        "title": "FPV/RTV"
                    }
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "69"
                                        }
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@spread": "4.6", 
                                            "@value": "10.2"
                                        }
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "39"
                                            }
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "30"
                                            }
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "35"
                                            }
                                        }, 
                                        "sub_title": "White/Caucasian"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "24"
                                            }
                                        }, 
                                        "sub_title": "Black"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "1"
                                            }
                                        }, 
                                        "sub_title": "East and South East Asian"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "8"
                                            }
                                        }, 
                                        "sub_title": "American Hispanic"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "1"
                                            }
                                        }, 
                                        "sub_title": "African Heritage"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Race/Ethnicity, Customized", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "The number of participants who prematurely discontinued study drug due to adverse events was tabulated.  Data are summarized by individual adverse event.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Fosamprenavir (FPV) 700 mg tablets or 50 mg/mL oral suspension/ritonavir (RTV) 100 mg capsules or 80 mg/mL oral solution once daily (QD)", 
                                "title": "FPV/RTV"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "69"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "12"
                                                    }
                                                }, 
                                                "sub_title": "Any event"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "3"
                                                    }
                                                }, 
                                                "sub_title": "Nausea"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "3"
                                                    }
                                                }, 
                                                "sub_title": "Vomiting"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "1"
                                                    }
                                                }, 
                                                "sub_title": "Stomach discomfort"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "1"
                                                    }
                                                }, 
                                                "sub_title": "Hyperglycaemia"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "1"
                                                    }
                                                }, 
                                                "sub_title": "Hypertriglyceridaemia"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "1"
                                                    }
                                                }, 
                                                "sub_title": "Blood alkaline phosphatase increased"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "1"
                                                    }
                                                }, 
                                                "sub_title": "Hodgkin's disease"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "1"
                                                    }
                                                }, 
                                                "sub_title": "Haemoptysis"
                                            }
                                        ]
                                    }, 
                                    "description": "The number of participants who prematurely discontinued study drug due to adverse events was tabulated.  Data are summarized by individual adverse event.", 
                                    "param": "Number", 
                                    "title": "Number of Participants Who Discontinued Treatment Due to Adverse Events", 
                                    "units": "Participants"
                                }
                            ]
                        }, 
                        "population": "Safety Population:  all participants with documented evidence of having received at least one dose of study drug", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline through end of study (at least Week 168)", 
                        "title": "Number of Participants Who Discontinued Treatment Due to Adverse Events", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "A blood sample was drawn to determine the amount of HIV-1 RNA virus in copies per milliliter (mL) at Weeks 12, 48, 96, and 196. The percentage of participants with HIV-1 RNA <400 copies/mL at Weeks 12, 48, 96, 168 was determined by the TLOVR algorithm with stratification by the six randomization strata. TLOVR analysis categorizes participants by treatment response. Responders were participants with confirmed viral load <400copies/mL on two consecutive visits.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants with equal to or less than 1 week of treatment with a Protease Inhibitor (PI)", 
                                    "title": "PI-Naive"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants treated with equal to or less than 3 PIs (any length of time)", 
                                    "title": "PI-Experienced"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "32"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "37"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "22"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "20"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Week 12"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "16"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "16"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Week 48"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "13"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "11"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Week 96"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "11"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "7"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Week 168"
                                            }
                                        ]
                                    }, 
                                    "description": "A blood sample was drawn to determine the amount of HIV-1 RNA virus in copies per milliliter (mL) at Weeks 12, 48, 96, and 196. The percentage of participants with HIV-1 RNA <400 copies/mL at Weeks 12, 48, 96, 168 was determined by the TLOVR algorithm with stratification by the six randomization strata. TLOVR analysis categorizes participants by treatment response. Responders were participants with confirmed viral load <400copies/mL on two consecutive visits.", 
                                    "param": "Number", 
                                    "title": "Percentage of Participants With HIV-1 RNA <400 Copies Per mL at Weeks 12, 48, 96, and 168 (Time to Loss of Virologic Response [TLOVR] Analysis)", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "population": "The Intent-to-Treat Exposed (ITT [E]) Population consisted of all subjects with documented evidence of having received at least one dose of study drug. Results are stratified by previous protease inhibitor (PI) experience. Participants with previous PI experience may respond differently to FPV.", 
                        "safety_issue": "No", 
                        "time_frame": "Weeks 12, 48, 96, and 168", 
                        "title": "Percentage of Participants With HIV-1 RNA <400 Copies Per mL at Weeks 12, 48, 96, and 168 (Time to Loss of Virologic Response [TLOVR] Analysis)", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "A blood sample was drawn to determine the amount of HIV-1 RNA virus in copies/mL at Weeks 12, 24, 48, 96, and 168.  Change from Baseline was defined as the HIV-1 RNA level at Weeks 12, 24, 48, 96, and 168 minus the HIV-1 RNA level at Baseline.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants with equal to or less than 1 week of treatment with a Protease Inhibitor (PI)", 
                                    "title": "PI-Naive"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants treated with equal to or less than 3 PIs (any length of time)", 
                                    "title": "PI-Experienced"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "32"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "37"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "-3.12", 
                                                            "@upper_limit": "-2.54", 
                                                            "@value": "-2.85"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "-3.02", 
                                                            "@upper_limit": "-0.64", 
                                                            "@value": "-2.03"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Week 12"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "-3.31", 
                                                            "@upper_limit": "-1.44", 
                                                            "@value": "-2.65"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "-2.76", 
                                                            "@upper_limit": "-1.02", 
                                                            "@value": "-1.65"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Week 48"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "-3.14", 
                                                            "@upper_limit": "-1.42", 
                                                            "@value": "-2.52"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "-2.91", 
                                                            "@upper_limit": "-0.57", 
                                                            "@value": "-1.76"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Week 96"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "-3.49", 
                                                            "@upper_limit": "-2.15", 
                                                            "@value": "-2.88"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "-3.13", 
                                                            "@upper_limit": "-0.94", 
                                                            "@value": "-2.39"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Week 168"
                                            }
                                        ]
                                    }, 
                                    "description": "A blood sample was drawn to determine the amount of HIV-1 RNA virus in copies/mL at Weeks 12, 24, 48, 96, and 168.  Change from Baseline was defined as the HIV-1 RNA level at Weeks 12, 24, 48, 96, and 168 minus the HIV-1 RNA level at Baseline.", 
                                    "dispersion": "Inter-Quartile Range", 
                                    "param": "Median", 
                                    "title": "Median Change From Baseline HIV-1 RNA Values at Weeks 12, 48, 96, and 168 Visits", 
                                    "units": "log10 copies/mL"
                                }
                            ]
                        }, 
                        "population": "ITT-E Population. Results are stratified by previous PI experience. Participants with previous PI experience may respond differently to FPV.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline and Weeks 12, 48, 96, and 168", 
                        "title": "Median Change From Baseline HIV-1 RNA Values at Weeks 12, 48, 96, and 168 Visits", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "A blood sample was drawn to determine the CD4+ cell count at Weeks 24, 48, 96, and 168. Change from Baseline was defined as the CD4+ cell count at Weeks 24, 48, 96, and 168 minus the CD4+ cell count at Baseline.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants with equal to or less than 1 week of treatment with a PI", 
                                    "title": "PI-Naive"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants treated with equal to or less than 3 PIs (any length of time)", 
                                    "title": "PI-Experienced"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "32"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "37"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "10", 
                                                            "@upper_limit": "150", 
                                                            "@value": "95"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "-30", 
                                                            "@upper_limit": "110", 
                                                            "@value": "40"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Week 12"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "75", 
                                                            "@upper_limit": "280", 
                                                            "@value": "150"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "240", 
                                                            "@value": "120"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Week 48"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "55", 
                                                            "@upper_limit": "280", 
                                                            "@value": "160"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "-180", 
                                                            "@upper_limit": "180", 
                                                            "@value": "40"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Week 96"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "10", 
                                                            "@upper_limit": "430", 
                                                            "@value": "180"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "-220", 
                                                            "@upper_limit": "200", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Week 168"
                                            }
                                        ]
                                    }, 
                                    "description": "A blood sample was drawn to determine the CD4+ cell count at Weeks 24, 48, 96, and 168. Change from Baseline was defined as the CD4+ cell count at Weeks 24, 48, 96, and 168 minus the CD4+ cell count at Baseline.", 
                                    "dispersion": "Inter-Quartile Range", 
                                    "param": "Median", 
                                    "title": "Median Change From Baseline in CD4+ Values at Week 12, 48, 96, and 168 Visits", 
                                    "units": "Cells/mm3"
                                }
                            ]
                        }, 
                        "population": "ITT-E Population. Results are stratified by previous PI experience. Participants with previous PI experience may respond differently to FPV.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline and Weeks 12, 48, 96, and 168", 
                        "title": "Median Change From Baseline in CD4+ Values at Week 12, 48, 96, and 168 Visits", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "The number of participants with drug-related adverse events coded as Grade 2 (mild), Grade 3 (severe), or Grade 4 (life-threatening).", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Fosamprenavir 700 mg tablets/ritonavir 100 mg capsules once daily", 
                                    "title": "FPV Tablet"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Fosamprenavir 50 mg/mL oral suspension/ritonavir 80 mg/mL oral solution once daily", 
                                    "title": "FPV Oral Suspension"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "24"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "45"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "7"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "14"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "All Grade 2-4 events"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "5"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Vomiting"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "2"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Diarrhea"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "2"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Nausea"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Blood alkaline phosphatase increased"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Blood triglycerides increased"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Abdominal pain"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Benign salivary gland neoplasm"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Blood cholesterol increased"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Eosinophil count increased"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Hemoptysis"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Hyperglycemia"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Hypertrichosis"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Lipodystrophy acquired"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Lipohypertrophy"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Rash"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Somnolence"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Stomach discomfort"
                                            }
                                        ]
                                    }, 
                                    "description": "The number of participants with drug-related adverse events coded as Grade 2 (mild), Grade 3 (severe), or Grade 4 (life-threatening).", 
                                    "param": "Number", 
                                    "title": "Number of Participants With Any Drug-related Grade 2 to 4 Adverse Event", 
                                    "units": "Participants"
                                }
                            ]
                        }, 
                        "population": "Safety Population:  all participants with documented evidence of having received at least one dose of study drug", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline through end of study (at least Week 168)", 
                        "title": "Number of Participants With Any Drug-related Grade 2 to 4 Adverse Event", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "The number of participants with Grade 3 (severe) or Grade 4 (life-threatening) laboratory abnormalities while on study treatment.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "Fosamprenavir (FPV) 700 mg tablets or 50 mg/mL oral suspension/ritonavir (RTV) 100 mg capsules or 80 mg/mL oral solution once daily (QD)", 
                                "title": "FPV/RTV"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "69"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "6"
                                                    }
                                                }, 
                                                "sub_title": "All parameters"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "2"
                                                    }
                                                }, 
                                                "sub_title": "Alanine aminotransferase"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "3"
                                                    }
                                                }, 
                                                "sub_title": "Aspartate aminotransferase"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "0"
                                                    }
                                                }, 
                                                "sub_title": "Cholesterol"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "0"
                                                    }
                                                }, 
                                                "sub_title": "Hyperglycemia"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "0"
                                                    }
                                                }, 
                                                "sub_title": "Hypoglycemia"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "0"
                                                    }
                                                }, 
                                                "sub_title": "Serum lipase"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "1"
                                                    }
                                                }, 
                                                "sub_title": "Triglycerides"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "1"
                                                    }
                                                }, 
                                                "sub_title": "Leucopenia"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "12"
                                                    }
                                                }, 
                                                "sub_title": "Neutropenia"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "2"
                                                    }
                                                }, 
                                                "sub_title": "Thrombocytopenia"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@value": "1"
                                                    }
                                                }, 
                                                "sub_title": "Anemia"
                                            }
                                        ]
                                    }, 
                                    "description": "The number of participants with Grade 3 (severe) or Grade 4 (life-threatening) laboratory abnormalities while on study treatment.", 
                                    "param": "Number", 
                                    "title": "Number of Participants With Grade 3 or 4 Treatment-emergent Laboratory Abnormalities", 
                                    "units": "Participants"
                                }
                            ]
                        }, 
                        "population": "Safety Population: all participants with documented evidence of having received at least one dose of study drug", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline through end of study (at least Week 168)", 
                        "title": "Number of Participants With Grade 3 or 4 Treatment-emergent Laboratory Abnormalities", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Geometric mean is a type of \"average\" that indicates the central tendency of a set of values and is calculated by multiplying all the numbers in a set, and then taking the nth root of the resulting product. AUC(0-tau)=area under the concentration curve from time 0 to tau.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 2-5 years", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 2-5 Years"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 6-11 years", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 6-11 Years"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 12-18 years", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 12-18 Years"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "FPV/RTV 1400/200 mg once daily (tablet), 12-18 years", 
                                    "title": "FPV/RTV 1400/200 mg Once Daily (Tablet), 12-18 Years"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "10"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "9"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "3"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "3"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "34.2", 
                                                        "@upper_limit": "65.4", 
                                                        "@value": "47.3"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "27.0", 
                                                        "@upper_limit": "84.0", 
                                                        "@value": "47.6"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@lower_limit": "23.4", 
                                                        "@upper_limit": "244", 
                                                        "@value": "75.5"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@lower_limit": "10.6", 
                                                        "@upper_limit": "486", 
                                                        "@value": "71.8"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Geometric mean is a type of \"average\" that indicates the central tendency of a set of values and is calculated by multiplying all the numbers in a set, and then taking the nth root of the resulting product. AUC(0-tau)=area under the concentration curve from time 0 to tau.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Geometric Mean", 
                                    "title": "Geometric Mean of Steady State Plasma Amprenavir (APV) Parameter: AUC(0-tau)", 
                                    "units": "hours*micrograms/milliliter"
                                }
                            ]
                        }, 
                        "population": "The Pharmacokinetic (PK) Parameter Population included all participants who underwent plasma PK sampling and provided full PK profiles with evaluable plasma APV PK parameter data; thus, the sample sizes were limited. Results are stratified by age cohort and formulation since these factors can impact PK profiles.", 
                        "safety_issue": "No", 
                        "time_frame": "0, 1, 2, 4, 8, 12, and 24 hours post dosing at Week 4", 
                        "title": "Geometric Mean of Steady State Plasma Amprenavir (APV) Parameter: AUC(0-tau)", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Geometric mean is a type of \"average\" that indicates the central tendency of a set of values and is calculated by multiplying all the numbers in a set, and then taking the nth root of the resulting product. Cmax= concentration maximum.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 2-5 years", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 2-5 Years"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 6-11 years", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 6-11 Years"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 12-18 years", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 12-18 Years"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "FPV/RTV 1400/200 mg once daily (tablet), 12-18 years", 
                                    "title": "FPV/RTV 1400/200 mg Once Daily (Tablet), 12-18 Years"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "10"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "9"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "3"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "3"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "3.76", 
                                                        "@upper_limit": "6.58", 
                                                        "@value": "4.97"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "2.50", 
                                                        "@upper_limit": "10.3", 
                                                        "@value": "5.07"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@lower_limit": "4.31", 
                                                        "@upper_limit": "11.0", 
                                                        "@value": "6.88"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@lower_limit": "2.70", 
                                                        "@upper_limit": "21.9", 
                                                        "@value": "7.70"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Geometric mean is a type of \"average\" that indicates the central tendency of a set of values and is calculated by multiplying all the numbers in a set, and then taking the nth root of the resulting product. Cmax= concentration maximum.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Geometric Mean", 
                                    "title": "Geometric Mean of Steady State Plasma APV Parameter: Cmax", 
                                    "units": "micrograms/milliliter"
                                }
                            ]
                        }, 
                        "population": "The PK Parameter Population included all participants who underwent plasma PK sampling and provided full PK profiles with evaluable plasma APV PK parameter data; thus, the sample sizes were limited. Results are stratified by age cohort and formulation since these factors can impact PK profiles.", 
                        "safety_issue": "No", 
                        "time_frame": "0, 1, 2, 4, 8, 12, and 24 hours post dosing at Week 4", 
                        "title": "Geometric Mean of Steady State Plasma APV Parameter: Cmax", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "A blood sample was drawn for participants failing to respond to therapy, and the mutations present in the virus were identified.  For each participant, the mutations found at the time of failure were compared with any mutations found in the blood sample at baseline.  New mutations that developed at the time of virologic failure were tabulated by drug class. Virologic failure is defined as HIV-1 RNA greater than or equal to 400 copies/mL.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants with equal to or less than 1 week of treatment with a PI", 
                                    "title": "PI-Naive"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants treated with equal to or less than 3 PIs (any length of time)", 
                                    "title": "PI-Experienced"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "32"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "37"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "2"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "2"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "A blood sample was drawn for participants failing to respond to therapy, and the mutations present in the virus were identified.  For each participant, the mutations found at the time of failure were compared with any mutations found in the blood sample at baseline.  New mutations that developed at the time of virologic failure were tabulated by drug class. Virologic failure is defined as HIV-1 RNA greater than or equal to 400 copies/mL.", 
                                    "param": "Number", 
                                    "title": "Number of Participants With APV Resistance Associated HIV-1 RNA Genotypic Mutations and Phenotypic Resistance at Time of Virologic Failure Not Present at Baseline", 
                                    "units": "Participants"
                                }
                            ]
                        }, 
                        "population": "Participants in the ITT-E Population who met the virologic failure definition. Results are stratified by previous PI experience. Participants with previous PI experience may respond differently to FPV.", 
                        "safety_issue": "No", 
                        "time_frame": "Time of virologic failure", 
                        "title": "Number of Participants With APV Resistance Associated HIV-1 RNA Genotypic Mutations and Phenotypic Resistance at Time of Virologic Failure Not Present at Baseline", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "tmax: time after administration of the drug when maximum concentration is reached", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 2-5 years", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 2-5 Years"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 6-11 years", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 6-11 Years"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 12-18 years", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 12-18 Years"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "FPV/RTV 1400/200 mg once daily (tablet), 12-18 years", 
                                    "title": "FPV/RTV 1400/200 mg Once Daily (Tablet), 12-18 Years"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "10"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "9"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "3"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "3"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "0.95", 
                                                        "@upper_limit": "4.02", 
                                                        "@value": "1.04"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "0.75", 
                                                        "@upper_limit": "2.07", 
                                                        "@value": "1.12"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@lower_limit": "0.92", 
                                                        "@upper_limit": "2.00", 
                                                        "@value": "1.08"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@lower_limit": "1.00", 
                                                        "@upper_limit": "4.00", 
                                                        "@value": "3.78"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "tmax: time after administration of the drug when maximum concentration is reached", 
                                    "dispersion": "Full Range", 
                                    "param": "Median", 
                                    "title": "Median Steady State Plasma APV Tmax", 
                                    "units": "hours"
                                }
                            ]
                        }, 
                        "population": "The PK Parameter Population included all participants who underwent plasma PK sampling and provided full PK profiles with evaluable plasma APV PK parameter data; thus, the sample sizes were limited. Results are stratified by age cohort and formulation since these factors can impact PK profiles.", 
                        "safety_issue": "No", 
                        "time_frame": "0, 1, 2, 4, 8, 12, and 24 hours post dosing at Week 4", 
                        "title": "Median Steady State Plasma APV Tmax", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Geometric mean is a type of \"average\" that indicates the central tendency of a set of values and is calculated by multiplying all the numbers in a set, and then taking the nth root of the resulting product.  CL/F=apparent plasma clearance.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 2-5 years vs. Historical Adult Data", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 2-5 Years"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 6-11 years vs. Historical Adult Data", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 6-11 Years"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 12-18 years vs. Historical Adult Data", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 12-18 Years"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "FPV/RTV 1400/200 mg once daily (tablet), 12-18 years vs. Historical Adult Data", 
                                    "title": "FPV/RTV 1400/200 mg Once Daily (Tablet), 12-18 Years"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "10"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "9"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "3"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "3"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "7.62", 
                                                        "@upper_limit": "14.5", 
                                                        "@value": "10.5"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "6.09", 
                                                        "@upper_limit": "18.5", 
                                                        "@value": "10.6"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@lower_limit": "2.08", 
                                                        "@upper_limit": "20.7", 
                                                        "@value": "6.57"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@lower_limit": "0.745", 
                                                        "@upper_limit": "32.9", 
                                                        "@value": "4.95"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Geometric mean is a type of \"average\" that indicates the central tendency of a set of values and is calculated by multiplying all the numbers in a set, and then taking the nth root of the resulting product.  CL/F=apparent plasma clearance.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Geometric Mean", 
                                    "title": "Geometric Mean of Steady State Plasma APV Parameter: CL/F", 
                                    "units": "milliliters/minute/kilogram"
                                }
                            ]
                        }, 
                        "population": "The PK Parameter Population included all participants who underwent plasma PK sampling and provided full PK profiles with evaluable plasma APV PK parameter data; thus, the sample sizes were limited. Results are stratified by age cohort and formulation since these factors can impact PK profiles.", 
                        "safety_issue": "No", 
                        "time_frame": "0, 1, 2, 4, 8, 12, and 24 hours post dosing at Week 4", 
                        "title": "Geometric Mean of Steady State Plasma APV Parameter: CL/F", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Geometric mean is a type of \"average\" that indicates the central tendency of a set of values and is calculated by multiplying all the numbers in a set, and then taking the nth root of the resulting product. CL/F=apparent plasma clearance.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "FPV/RTV 1400/200 mg once daily (tablet), 12-18 years", 
                                "title": "FPV/RTV 1400/200 mg Once Daily (Tablet), 12-18 Years"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "3"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@lower_limit": "41.2", 
                                                    "@upper_limit": "1882", 
                                                    "@value": "278"
                                                }
                                            }
                                        }
                                    }, 
                                    "description": "Geometric mean is a type of \"average\" that indicates the central tendency of a set of values and is calculated by multiplying all the numbers in a set, and then taking the nth root of the resulting product. CL/F=apparent plasma clearance.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Geometric Mean", 
                                    "title": "Geometric Mean of Steady State Plasma APV Parameter: CL/F", 
                                    "units": "milliliters/minute"
                                }
                            ]
                        }, 
                        "population": "The PK Parameter Population included all participants who underwent plasma PK sampling and provided full PK profiles with evaluable plasma APV PK parameter data; thus, the sample sizes were limited. Results are stratified by age cohort and formulation since these factors can impact PK profiles.", 
                        "safety_issue": "No", 
                        "time_frame": "0, 1, 2, 4, 8, 12, and 24 hours post dosing at Week 4", 
                        "title": "Geometric Mean of Steady State Plasma APV Parameter: CL/F", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Geometric mean is a type of \"average\" that indicates the central tendency of a set of values and is calculated by multiplying all the numbers in a set, and then taking the nth root of the resulting product.  t1/2=elimination half-life. t1/2=elimination half-life.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 2-5 years", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 2-5 Years"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 6-11 years", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 6-11 Years"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 12-18 years", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 12-18 Years"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "FPV/RTV 1400/200 mg once daily (tablet), 12-18 years", 
                                    "title": "FPV/RTV 1400/200 mg Once Daily (Tablet), 12-18 Years"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "10"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "9"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "3"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "3"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "11.1", 
                                                        "@upper_limit": "27.7", 
                                                        "@value": "17.5"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "9.02", 
                                                        "@upper_limit": "20.4", 
                                                        "@value": "13.6"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@lower_limit": "7.93", 
                                                        "@upper_limit": "28.2", 
                                                        "@value": "15.0"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@lower_limit": "4.78", 
                                                        "@upper_limit": "46.4", 
                                                        "@value": "14.9"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Geometric mean is a type of \"average\" that indicates the central tendency of a set of values and is calculated by multiplying all the numbers in a set, and then taking the nth root of the resulting product.  t1/2=elimination half-life. t1/2=elimination half-life.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Geometric Mean", 
                                    "title": "Geometric Mean of Steady State Plasma APV Parameter: t1/2", 
                                    "units": "hours"
                                }
                            ]
                        }, 
                        "population": "The PK Parameter Population included all participants who underwent plasma PK sampling and provided full PK profiles with evaluable plasma APV PK parameter data; thus, the sample sizes were limited. Results are stratified by age cohort and formulation since these factors can impact PK profiles.", 
                        "safety_issue": "No", 
                        "time_frame": "0, 1, 2, 4, 8, 12, and 24 hours post dosing at Week 4", 
                        "title": "Geometric Mean of Steady State Plasma APV Parameter: t1/2", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "A blood sample was drawn on Week 4 over 24 hours (at 0, 1, 2, 4, 8, 12, and 24 hours post dosing).  Ratio of geometric least squares mean (90% CI) are presented.  Ctau=trough concentration. PK Parameters for QD and BID are compared with Historical adult data. Least squares mean (LSM) are the group means after having controlled for a covariate (i.e., holding it constant at some typical value of the covariate, such as its mean value).  LSM is calculated by taking the average of the means within a treatment.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 2-5 years vs. Historical Adult Data", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 2-5 Years"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 6-11 years vs. Historical Adult Data", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 6-11 Years"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 12-18 years vs. Historical Adult Data", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 12-18 Years"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "FPV/RTV 1400/200 mg once daily (tablet), 12-18 years vs. Historical Adult Data", 
                                    "title": "FPV/RTV 1400/200 mg Once Daily (Tablet), 12-18 Years"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "10"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "9"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "3"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "3"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "0.578", 
                                                        "@upper_limit": "0.835", 
                                                        "@value": "0.695"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "0.577", 
                                                        "@upper_limit": "0.848", 
                                                        "@value": "0.699"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@lower_limit": "0.800", 
                                                        "@upper_limit": "1.54", 
                                                        "@value": "1.11"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@lower_limit": "0.761", 
                                                        "@upper_limit": "1.47", 
                                                        "@value": "1.06"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "A blood sample was drawn on Week 4 over 24 hours (at 0, 1, 2, 4, 8, 12, and 24 hours post dosing).  Ratio of geometric least squares mean (90% CI) are presented.  Ctau=trough concentration. PK Parameters for QD and BID are compared with Historical adult data. Least squares mean (LSM) are the group means after having controlled for a covariate (i.e., holding it constant at some typical value of the covariate, such as its mean value).  LSM is calculated by taking the average of the means within a treatment.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Least Squares Mean", 
                                    "title": "Least Squares Mean of Plasma APV Parameter: AUC0-tau", 
                                    "units": "hours*micrograms/milliliters"
                                }
                            ]
                        }, 
                        "population": "The PK Parameter Population included all participants who underwent plasma PK sampling and provided full PK profiles with evaluable plasma APV PK parameter data; thus, the sample sizes were limited. Results are stratified by age cohort and formulation since these factors can impact PK profiles.", 
                        "safety_issue": "No", 
                        "time_frame": "0, 1, 2, 4, 8, 12, and 24 hours post dosing at Week 4", 
                        "title": "Least Squares Mean of Plasma APV Parameter: AUC0-tau", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "A blood sample was drawn on Week 4 over 24 hours (at 0, 1, 2, 4, 8, 12, and 24 hours post dosing).  Ratio of geometric least squares mean (90% CI) are presented.  Ctau=trough concentration. PK Parameters for QD and BID are compared with Historical adult data. Least squares mean (LSM) are the group means after having controlled for a covariate (i.e., holding it constant at some typical value of the covariate, such as its mean value).  LSM is calculated by taking the average of the means within a treatment.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 2-5 years vs. Historical Adult Data", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 2-5 Years"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 6-11 years vs. Historical Adult Data", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 6-11 Years"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 12-18 years vs. Historical Adult Data", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 12-18 Years"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "FPV/RTV 1400/200 mg once daily (tablet), 12-18 years vs. Historical Adult Data", 
                                    "title": "FPV/RTV 1400/200 mg Once Daily (Tablet), 12-18 Years"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "10"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "9"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "3"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "3"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "0.555", 
                                                        "@upper_limit": "0.791", 
                                                        "@value": "0.663"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "0.560", 
                                                        "@upper_limit": "0.814", 
                                                        "@value": "0.676"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@lower_limit": "0.667", 
                                                        "@upper_limit": "1.26", 
                                                        "@value": "0.917"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@lower_limit": "0.747", 
                                                        "@upper_limit": "1.41", 
                                                        "@value": "1.03"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "A blood sample was drawn on Week 4 over 24 hours (at 0, 1, 2, 4, 8, 12, and 24 hours post dosing).  Ratio of geometric least squares mean (90% CI) are presented.  Ctau=trough concentration. PK Parameters for QD and BID are compared with Historical adult data. Least squares mean (LSM) are the group means after having controlled for a covariate (i.e., holding it constant at some typical value of the covariate, such as its mean value).  LSM is calculated by taking the average of the means within a treatment.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Least Squares Mean", 
                                    "title": "Least Squares Mean of Plasma APV Parameter: Cmax", 
                                    "units": "micrograms/milliliters"
                                }
                            ]
                        }, 
                        "population": "The PK Parameter Population included all participants who underwent plasma PK sampling and provided full PK profiles with evaluable plasma APV PK parameter data; thus, the sample sizes were limited. Results are stratified by age cohort and formulation since these factors can impact PK profiles.", 
                        "safety_issue": "No", 
                        "time_frame": "0, 1, 2, 4, 8, 12, and 24 hours post dosing at Week 4.", 
                        "title": "Least Squares Mean of Plasma APV Parameter: Cmax", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "A blood sample was drawn on Week 4 over 24 hours (at 0, 1, 2, 4, 8, 12, and 24 hours post dosing).  Ratio of geometric least squares mean (90% CI) are presented.  Ctau=trough concentration. PK Parameters for QD and BID are compared with Historical adult data. Least squares mean (LSM) are the group means after having controlled for a covariate (i.e., holding it constant at some typical value of the covariate, such as its mean value).  LSM is calculated by taking the average of the means within a treatment.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 2-5 years", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 2-5 Years"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 6-11 years", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 6-11 Years"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "FPV/RTV 30/6 mg/kg once daily (suspension), 12-18 years", 
                                    "title": "FPV/RTV 30/6 mg/kg Once Daily (Suspension), 12-18 Years"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "FPV/RTV 1400/200 mg once daily (tablet), 12-18 years", 
                                    "title": "FPV/RTV 1400/200 mg Once Daily (Tablet), 12-18 Years"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "10"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "9"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "3"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "3"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "0.548", 
                                                        "@upper_limit": "0.936", 
                                                        "@value": "0.716"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "0.663", 
                                                        "@upper_limit": "1.06", 
                                                        "@value": "0.837"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@lower_limit": "0.696", 
                                                        "@upper_limit": "1.33", 
                                                        "@value": "0.963"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@lower_limit": "0.568", 
                                                        "@upper_limit": "0.878", 
                                                        "@value": "0.706"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "A blood sample was drawn on Week 4 over 24 hours (at 0, 1, 2, 4, 8, 12, and 24 hours post dosing).  Ratio of geometric least squares mean (90% CI) are presented.  Ctau=trough concentration. PK Parameters for QD and BID are compared with Historical adult data. Least squares mean (LSM) are the group means after having controlled for a covariate (i.e., holding it constant at some typical value of the covariate, such as its mean value).  LSM is calculated by taking the average of the means within a treatment.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Least Squares Mean", 
                                    "title": "Least Squares Mean of Plasma APV Parameter: Ctau", 
                                    "units": "microgram per milliliter"
                                }
                            ]
                        }, 
                        "population": "The PK Parameter Population included all participants who underwent plasma PK sampling and provided full PK profiles with evaluable plasma APV PK parameter data; thus, the sample sizes were limited. Results are stratified by age cohort and formulation since these factors can impact PK profiles.", 
                        "safety_issue": "No", 
                        "time_frame": "0, 1, 2, 4, 8, 12, and 24 hours post dosing at Week 4.", 
                        "title": "Least Squares Mean of Plasma APV Parameter: Ctau", 
                        "type": "Primary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "Fosamprenavir (FPV) 700 mg tablets or 50 mg/mL oral suspension/ritonavir (RTV) 100 mg capsules or 80 mg/mL oral solution once daily (QD)", 
                            "title": "Overall Fosamprenavir (FPV)/Ritonavir(RTV)"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "Fosamprenavir (FPV) 700 mg tablets or 50 mg/mL oral suspension/ritonavir (RTV) 100 mg capsules or 80 mg/mL oral solution once daily (QD), 2-5 years", 
                            "title": "2-5 Years FPV/RTV"
                        }, 
                        {
                            "@group_id": "P3", 
                            "description": "Fosamprenavir (FPV) 700 mg tablets or 50 mg/mL oral suspension/ritonavir (RTV) 100 mg capsules or 80 mg/mL oral solution once daily (QD), 6-11 years", 
                            "title": "6-11 Years FPV/RTV"
                        }, 
                        {
                            "@group_id": "P4", 
                            "description": "Fosamprenavir (FPV) 700 mg tablets or 50 mg/mL oral suspension/ritonavir (RTV) 100 mg capsules or 80 mg/mL oral solution once daily (QD), 12-18 years", 
                            "title": "12-18 Years FPV/RTV"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "drop_withdraw_reason_list": {
                            "drop_withdraw_reason": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "12", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "3", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "2", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "7", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "Adverse Event"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "9", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "2", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "3", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "4", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "Lack of Efficacy"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "1", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "Insufficient CD4 response"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "4", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "2", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "2", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "Lost to Follow-up"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "2", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "Protocol Violation"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "7", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "3", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "4", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "Withdrawal by Subject"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "3", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "3", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "Pregnancy"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "8", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "2", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "5", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "Medication adherence/compliance problems"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "2", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "2", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "Poor taste"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "2", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "Pharmacokinetic target not achieved"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "2", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "2", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "Change of formulation"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "1", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "Non-viability of oral suspension"
                                }
                            ]
                        }, 
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "#text": "All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.", 
                                                "@count": "69", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "17", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "17", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "35", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "16", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "4", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "4", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "8", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "53", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "13", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "13", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "27", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }, 
                "pre_assignment_details": "The overall study population consisted of 69 participants presented as \"Overall Fosamprenavir (FPV)/ritonavir (RTV)\" in the Participant Flow section. Furthermore, the Overall FPV/RTV participants are stratified by age cohorts (Arms 2-4).", 
                "recruitment_details": "Cohorts were recruited in parallel. All Age Cohorts were given the same treatment."
            }, 
            "point_of_contact": {
                "name_or_title": "GSK Response Center", 
                "organization": "GlaxoSmithKline", 
                "phone": "866-435-7343"
            }, 
            "reported_events": {
                "group_list": {
                    "group": {
                        "@group_id": "E1", 
                        "description": "Fosamprenavir (FPV) 700 mg tablets or 50 mg/mL oral suspension/ritonavir (RTV) 100 mg capsules or 80 mg/mL oral solution once daily (QD)", 
                        "title": "FPV/RTV"
                    }
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "63"
                                        }, 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "4", 
                                            "@subjects_at_risk": "69"
                                        }, 
                                        "sub_title": "Lymphadenopathy"
                                    }
                                }, 
                                "title": "Blood and lymphatic system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "4", 
                                            "@subjects_at_risk": "69"
                                        }, 
                                        "sub_title": "Conjunctivitis"
                                    }
                                }, 
                                "title": "Eye disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "28", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Vomiting"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "18", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Diarrhoea"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "16", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Nausea"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "7", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Abdominal pain"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "4", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Abdominal pain upper"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "4", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Dental caries"
                                        }
                                    ]
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "10", 
                                            "@subjects_at_risk": "69"
                                        }, 
                                        "sub_title": "Pyrexia"
                                    }
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "17", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Upper respiratory tract infection"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "12", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Bronchitis"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "11", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Nasopharyngitis"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "8", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Otitis media"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "6", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Influenza"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "4", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Oral herpes"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "4", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Pharyngitis"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "4", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Pharyngitis streptococcal"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "4", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Sinusitis"
                                        }
                                    ]
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "4", 
                                            "@subjects_at_risk": "69"
                                        }, 
                                        "sub_title": "Arthropod bite"
                                    }
                                }, 
                                "title": "Injury, poisoning and procedural complications"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "4", 
                                            "@subjects_at_risk": "69"
                                        }, 
                                        "sub_title": "Skin papilloma"
                                    }
                                }, 
                                "title": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "17", 
                                            "@subjects_at_risk": "69"
                                        }, 
                                        "sub_title": "Headache"
                                    }
                                }, 
                                "title": "Nervous system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "16", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Cough"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "6", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Nasal congestion"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "5", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Pharyngolaryngeal pain"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "5", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Rhinorrhoea"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "4", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Epistaxis"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "4", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Rhinitis allergic"
                                        }
                                    ]
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "10", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Rash"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "4", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Acne"
                                        }
                                    ]
                                }, 
                                "title": "Skin and subcutaneous tissue disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "MedDRA", 
                    "frequency_threshold": "5"
                }, 
                "serious_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "19"
                                        }, 
                                        "sub_title": "Total, serious adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "69"
                                        }, 
                                        "sub_title": "Anemia"
                                    }
                                }, 
                                "title": "Blood and lymphatic system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "2", 
                                            "@subjects_at_risk": "69"
                                        }, 
                                        "sub_title": "Pyrexia"
                                    }
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "69"
                                        }, 
                                        "sub_title": "Hepatitis"
                                    }
                                }, 
                                "title": "Hepatobiliary disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "3", 
                                            "@subjects_at_risk": "69"
                                        }, 
                                        "sub_title": "Drug hypersensitivity"
                                    }
                                }, 
                                "title": "Immune system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Measles"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Appendicitis"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Gastroenteritis"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Pneumonia"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Pneumonia bacterial"
                                        }
                                    ]
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "69"
                                        }, 
                                        "sub_title": "Eye penetration"
                                    }
                                }, 
                                "title": "Injury, poisoning and procedural complications"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "69"
                                        }, 
                                        "sub_title": "Blood alkaline phosphatase increased"
                                    }
                                }, 
                                "title": "Investigations"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "69"
                                        }, 
                                        "sub_title": "Hyperglycemia"
                                    }
                                }, 
                                "title": "Metabolism and nutrition disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "69"
                                        }, 
                                        "sub_title": "Benign salivary gland neoplasm"
                                    }
                                }, 
                                "title": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "69"
                                        }, 
                                        "sub_title": "Headache"
                                    }
                                }, 
                                "title": "Nervous system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Aggression"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Anxiety"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Bipolar disorder"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Borderline personality disorder"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Depression"
                                        }, 
                                        {
                                            "counts": {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "69"
                                            }, 
                                            "sub_title": "Impulse control disorder"
                                        }
                                    ]
                                }, 
                                "title": "Psychiatric disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "1", 
                                            "@subjects_at_risk": "69"
                                        }, 
                                        "sub_title": "Hemoptysis"
                                    }
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "MedDRA"
                }
            }
        }, 
        "completion_date": {
            "#text": "October 2008", 
            "@type": "Actual"
        }, 
        "condition": "HIV Infection", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "A 48 Week, Phase II, Open-label, Multi-Cohort, Multicenter Study to Evaluate the Safety,\n      Tolerability, Pharmacokinetics and Antiviral Activity of GW433908/Ritonavir QD and\n      GW433908/Ritonavir BID when Administered to HIV-1 Infected, Antiretroviral Naive and\n      Experience Pediatric Subjects 2 to 18 Years Old\n\n      ViiV Healthcare is the new sponsor of this study, and GlaxoSmithKline is in the process of\n      updating systems to reflect the change in sponsorship"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  Inclusion Criteria:\n\n          -  Male or females 2 to 18 years of age\n\n          -  A female is eligible to enter and participate in this study if she is of:\n\n          -  a. non-childbearing potential (i.e., physiologically incapable of becoming pregnant,\n             including any female who is pre-menarchial); or,\n\n          -  b. child-bearing potential with a negative serum pregnancy test at screen, a negative\n             urine pregnancy test on Day 1 and who agrees to use one of the following methods of\n             contraception (any contraception method must be used consistently and correctly,\n             i.e., in accordance with both the product label and the instructions of a physician).\n             Note: hormonal contraceptives are not considered a sufficient form of contraceptive\n             for this study.\n\n          -  Complete abstinence from intercourse from 2 weeks prior to administration of study\n             drugs, throughout the study and for 2 weeks after discontinuation of all study\n             medications.  Should a female subject of childbearing potential decide to become\n             sexually active during the course of the study, she must be counselled and be willing\n             to use one of the methods listed below:\n\n          -  Double barrier contraception (male condom/spermicide, male condom/diaphragm,\n             diaphragm/spermicide)\n\n          -  Any intrauterine device (IUD) with published data showing that the expected failure\n             rate is less than 1% per year (not all IUDs meet this criterion)\n\n          -  Any other method with published data showing that the lowest expected failure rate\n             for that method is less than 1% per year. All subjects participating in this study\n             should be counselled on the practice of safe/safer sex.\n\n          -  Parent or legal guardian (and subject whenever possible) has the ability to\n             understand and provide written informed consent for the subject to participate in the\n             trial.  Verbal witnessed assent must be obtained from the subject whenever possible.\n\n          -  Screening plasma HIV-1 RNA > or =400copies/mL.\n\n          -  Subject's who, in the investigator's opinion, and following resistance testing where\n             appropriate, are able to construct an active NRTI backbone regimen consisting of 2\n             NRTIs.\n\n          -  Subjects must meet one of the following criteria:\n\n          -  ART-na\u00efve subjects are defined as having had < 4 weeks (28 days) therapy with an\n             NRTI, no previous therapy with an NNRTI and < 1 week therapy with an HIV PI.\n\n          -  ART-experienced subjects are defined as having had greater than 4 weeks (28 days)\n             therapy with any NRTI(s) and any length of therapy with any NNRTI(s) and/or a PI.\n             PI-experienced subjects will be eligible if they have previously been treated with <\n             three PIs, excluding AGENERASE. Prior therapy with a RTV boosted PI regimen will be\n             considered as only 1 prior PI as long as the RTV dose was below that recommended for\n             use of RTV as an antiretroviral agent. This specific criterion is not applicable to\n             subjects in screening and/or enrolling after approval of Amendment No. 4.\n                                                                              - For subjects\n             screening and/or enrolling after the approval of Amendment No.4, PI naive subjects\n             are defined as ART experienced subjects having less than one week of therapy with a\n             PI and no prior experience with AGENERASE. Prior treatment with NNRTIs and NRTIs is\n             permitted (however, subjects will NOT be permitted to receive concurrent NNRTI\n             therapy while participating in this study)\n\n          -  Exclusion Criteria:\n\n          -  Prior history of having received amprenavir.\n\n          -  Use of non-nucleoside reverse transcriptase inhibitor (NNRTI) therapy within 14 days\n             of study Day 1 or anticipated need for concurrent NNRTI therapy during the study\n             period.\n\n          -  Have had an AIDS defining illness (acute CDC Category C event) within 28 days of\n             screening.\n\n          -  Pregnant or lactating.\n\n          -  Non-nucleoside reverse transcriptase inhibitor therapy within 14 days prior to study\n             drug administration or anticipated need for concurrent NNRTI therapy during the study\n             period.\n\n          -  Subjects who, in the investigator's opinion, are not able to comply with the\n             requirements of the study.\n\n          -  An acute CDC Category C event (per 1993/1994 classification) and/or serious bacterial\n             infection(s) within 28 days prior to study drug administration.\n\n          -  Presence of a malabsorption syndrome or other gastrointestinal dysfunction which\n             might interfere with drug absorption or render the subject unable to take oral\n             medication.\n\n          -  Presence of any serious medical condition (e.g., hemoglobinopathy, chronic\n             anemia,diabetes, cardiac dysfunction and hepatitis) which, in the opinion of the\n             investigator, might compromise the safety of the subject.\n\n          -  Current grade 2 or higher serum lipase within 28 days prior to study drug\n             administration and/or history of clinically relevant pancreatitis within the previous\n             6 months.                                                                         -\n             Grade 3 or 4 transaminase levels (ALT and/or AST) within 28 days prior to study drug\n             administration and/or clinically relevant hepatitis within the previous 6 months.\n\n          -  Treatment with radiation therapy or cytotoxic chemotherapeutic agents within 28 days\n             of study drug administration or an anticipated need for such treatment within the\n             study period.\n\n          -  Treatment with immunomodulating agents (e.g., systemic corticosteroids, interleukins,\n             interferons) or any agent with known anti-HIV activity (e.g., hydroxyurea or\n             foscarnet) within 28 days of study drug administration.\n\n          -  Treatment with any of the following medications within 28 days prior to receiving\n             study medication or the anticipated need during the study:\n\n          -  Amiodarone, astemizole, bepridil, bupropion, cisapride, clorazepate, clozapine,\n             diazepin, dihydroergotamine, encainide, ergonovine, ergotamine, estazolam,\n             flecainide, flurazepam, lovastatin, meperidine, methylergonovine, midazolam,\n             pimozide, piroxicam, propafenone, propoxyphene, quinidine, rifabutin, simvastatin,\n             terfenadine, triazolam, zolpidem (these drugs have been excluded for safety reasons).\n\n          -  Carbamazepine, dexamethasone, phenobarbital, phenytoin, primidone, rifampin, St Johns\n             Wort (these drugs have been excluded because they have the potential to decrease\n             plasma protease inhibitor concentrations)\n                                 - Systemic chemotherapeutic agents\n\n          -  Treatment with other investigational drugs/therapies (note: treatments available\n             through a Treatment IND or other expanded-access mechanism will be evaluated on a\n             case-by-case basis in consultation with the sponsor) within 28 days prior to study\n             drug administration\n\n          -  History of drug or other allergy which, in the opinion of the investigator,\n             contraindicates participation in the trial or known hypersensitivity to any study\n             medications (e.g., documented hypersensitivity to a nucleoside analogue)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "2 Years"
        }, 
        "enrollment": {
            "#text": "69", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 5, 2002", 
        "firstreceived_results_date": "August 6, 2009", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00040664", 
            "org_study_id": "APV 20003"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "12 to 18 years (FPV/RTV)", 
                    "2 to 5 years  (FPV/RTV)", 
                    "6 to 11 years (FPV/RTV)"
                ], 
                "description": "ritonavir oral capsules or oral solution", 
                "intervention_name": "ritonavir", 
                "intervention_type": "Drug", 
                "other_name": [
                    "fosamprenavir", 
                    "ritonavir"
                ]
            }, 
            {
                "arm_group_label": [
                    "12 to 18 years (FPV/RTV)", 
                    "2 to 5 years  (FPV/RTV)", 
                    "6 to 11 years (FPV/RTV)"
                ], 
                "description": "fosamprenavir oral suspension or tablet", 
                "intervention_name": "fosamprenavir", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ritonavir", 
                "Fosamprenavir"
            ]
        }, 
        "keyword": [
            "pediatrics", 
            "HIV", 
            "protease inhibitors", 
            "ritonavir", 
            "fosamprenavir", 
            "LEXIVA", 
            "AGENERASE", 
            "amprenavir"
        ], 
        "lastchanged_date": "January 24, 2011", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35233"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90027"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jacksonville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32209"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33613"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60614"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70112"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02118"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10457"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stony Brook", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11794-8111"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chapel Hill", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27599-7220"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27705"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44106"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75235"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Worth", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "76104"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23298"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M5G 1X8"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montreal", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "H3T 1C5"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Modena", 
                        "country": "Italy", 
                        "state": "Emilia-Romagna", 
                        "zip": "41150"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy", 
                        "state": "Lazio", 
                        "zip": "00165"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Genova", 
                        "country": "Italy", 
                        "state": "Liguria", 
                        "zip": "16132"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "state": "Lombardia", 
                        "zip": "20142"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "state": "Lombardia", 
                        "zip": "20122"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pavia", 
                        "country": "Italy", 
                        "state": "Lombardia", 
                        "zip": "27100"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Firenze", 
                        "country": "Italy", 
                        "state": "Toscana", 
                        "zip": "55100"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Padova", 
                        "country": "Italy", 
                        "state": "Veneto", 
                        "zip": "35128"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rotterdam", 
                        "country": "Netherlands", 
                        "zip": "3015 GE"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amadora", 
                        "country": "Portugal", 
                        "zip": "2700"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lisboa", 
                        "country": "Portugal", 
                        "zip": "1150"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lisboa", 
                        "country": "Portugal", 
                        "zip": "1649-035"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bucharest", 
                        "country": "Romania", 
                        "zip": "030303"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bucharest", 
                        "country": "Romania", 
                        "zip": "021105"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08950"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08035"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08003"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28007"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28041"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28047"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Palma de Mallorca", 
                        "country": "Spain", 
                        "zip": "07014"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain", 
                        "zip": "41013"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain", 
                        "zip": "46009"
                    }, 
                    "name": "GSK Investigational Site"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada", 
                "Italy", 
                "Netherlands", 
                "Portugal", 
                "Romania", 
                "Spain"
            ]
        }, 
        "number_of_arms": "3", 
        "official_title": "See Detailed Description", 
        "overall_official": {
            "affiliation": "GlaxoSmithKline", 
            "last_name": "GSK Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Canada: Health Canada", 
                "Italy: The Italian Medicines Agency", 
                "Spain: Spanish Agency of Medicines", 
                "United States: Food and Drug Administration"
            ]
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2008", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "The number of participants who prematurely discontinued study drug due to adverse events was tabulated.  Data are summarized by individual adverse event.", 
                "measure": "Number of Participants Who Discontinued Treatment Due to Adverse Events", 
                "safety_issue": "No", 
                "time_frame": "Baseline through end of study (at least Week 168)"
            }, 
            {
                "description": "The number of participants with drug-related adverse events coded as Grade 2 (mild), Grade 3 (severe), or Grade 4 (life-threatening).", 
                "measure": "Number of Participants With Any Drug-related Grade 2 to 4 Adverse Event", 
                "safety_issue": "No", 
                "time_frame": "Baseline through end of study (at least Week 168)"
            }, 
            {
                "description": "The number of participants with Grade 3 (severe) or Grade 4 (life-threatening) laboratory abnormalities while on study treatment.", 
                "measure": "Number of Participants With Grade 3 or 4 Treatment-emergent Laboratory Abnormalities", 
                "safety_issue": "No", 
                "time_frame": "Baseline through end of study (at least Week 168)"
            }, 
            {
                "description": "Geometric mean is a type of \"average\" that indicates the central tendency of a set of values and is calculated by multiplying all the numbers in a set, and then taking the nth root of the resulting product. AUC(0-tau)=area under the concentration curve from time 0 to tau.", 
                "measure": "Geometric Mean of Steady State Plasma Amprenavir (APV) Parameter: AUC(0-tau)", 
                "safety_issue": "No", 
                "time_frame": "0, 1, 2, 4, 8, 12, and 24 hours post dosing at Week 4"
            }, 
            {
                "description": "Geometric mean is a type of \"average\" that indicates the central tendency of a set of values and is calculated by multiplying all the numbers in a set, and then taking the nth root of the resulting product. Cmax= concentration maximum.", 
                "measure": "Geometric Mean of Steady State Plasma APV Parameter: Cmax", 
                "safety_issue": "No", 
                "time_frame": "0, 1, 2, 4, 8, 12, and 24 hours post dosing at Week 4"
            }, 
            {
                "description": "tmax: time after administration of the drug when maximum concentration is reached", 
                "measure": "Median Steady State Plasma APV Tmax", 
                "safety_issue": "No", 
                "time_frame": "0, 1, 2, 4, 8, 12, and 24 hours post dosing at Week 4"
            }, 
            {
                "description": "Geometric mean is a type of \"average\" that indicates the central tendency of a set of values and is calculated by multiplying all the numbers in a set, and then taking the nth root of the resulting product.  CL/F=apparent plasma clearance.", 
                "measure": "Geometric Mean of Steady State Plasma APV Parameter: CL/F", 
                "safety_issue": "No", 
                "time_frame": "0, 1, 2, 4, 8, 12, and 24 hours post dosing at Week 4"
            }, 
            {
                "description": "Geometric mean is a type of \"average\" that indicates the central tendency of a set of values and is calculated by multiplying all the numbers in a set, and then taking the nth root of the resulting product. CL/F=apparent plasma clearance.", 
                "measure": "Geometric Mean of Steady State Plasma APV Parameter: CL/F", 
                "safety_issue": "No", 
                "time_frame": "0, 1, 2, 4, 8, 12, and 24 hours post dosing at Week 4"
            }, 
            {
                "description": "Geometric mean is a type of \"average\" that indicates the central tendency of a set of values and is calculated by multiplying all the numbers in a set, and then taking the nth root of the resulting product.  t1/2=elimination half-life. t1/2=elimination half-life.", 
                "measure": "Geometric Mean of Steady State Plasma APV Parameter: t1/2", 
                "safety_issue": "No", 
                "time_frame": "0, 1, 2, 4, 8, 12, and 24 hours post dosing at Week 4"
            }, 
            {
                "description": "A blood sample was drawn on Week 4 over 24 hours (at 0, 1, 2, 4, 8, 12, and 24 hours post dosing).  Ratio of geometric least squares mean (90% CI) are presented.  Ctau=trough concentration. PK Parameters for QD and BID are compared with Historical adult data. Least squares mean (LSM) are the group means after having controlled for a covariate (i.e., holding it constant at some typical value of the covariate, such as its mean value).  LSM is calculated by taking the average of the means within a treatment.", 
                "measure": "Least Squares Mean of Plasma APV Parameter: AUC0-tau", 
                "safety_issue": "No", 
                "time_frame": "0, 1, 2, 4, 8, 12, and 24 hours post dosing at Week 4"
            }, 
            {
                "description": "A blood sample was drawn on Week 4 over 24 hours (at 0, 1, 2, 4, 8, 12, and 24 hours post dosing).  Ratio of geometric least squares mean (90% CI) are presented.  Ctau=trough concentration. PK Parameters for QD and BID are compared with Historical adult data. Least squares mean (LSM) are the group means after having controlled for a covariate (i.e., holding it constant at some typical value of the covariate, such as its mean value).  LSM is calculated by taking the average of the means within a treatment.", 
                "measure": "Least Squares Mean of Plasma APV Parameter: Cmax", 
                "safety_issue": "No", 
                "time_frame": "0, 1, 2, 4, 8, 12, and 24 hours post dosing at Week 4."
            }, 
            {
                "description": "A blood sample was drawn on Week 4 over 24 hours (at 0, 1, 2, 4, 8, 12, and 24 hours post dosing).  Ratio of geometric least squares mean (90% CI) are presented.  Ctau=trough concentration. PK Parameters for QD and BID are compared with Historical adult data. Least squares mean (LSM) are the group means after having controlled for a covariate (i.e., holding it constant at some typical value of the covariate, such as its mean value).  LSM is calculated by taking the average of the means within a treatment.", 
                "measure": "Least Squares Mean of Plasma APV Parameter: Ctau", 
                "safety_issue": "No", 
                "time_frame": "0, 1, 2, 4, 8, 12, and 24 hours post dosing at Week 4."
            }
        ], 
        "removed_countries": {
            "country": "United Kingdom"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00040664"
        }, 
        "responsible_party": {
            "name_title": "Study Director", 
            "organization": "GSK"
        }, 
        "secondary_outcome": [
            {
                "description": "A blood sample was drawn to determine the amount of HIV-1 RNA virus in copies per milliliter (mL) at Weeks 12, 48, 96, and 196. The percentage of participants with HIV-1 RNA <400 copies/mL at Weeks 12, 48, 96, 168 was determined by the TLOVR algorithm with stratification by the six randomization strata. TLOVR analysis categorizes participants by treatment response. Responders were participants with confirmed viral load <400copies/mL on two consecutive visits.", 
                "measure": "Percentage of Participants With HIV-1 RNA <400 Copies Per mL at Weeks 12, 48, 96, and 168 (Time to Loss of Virologic Response [TLOVR] Analysis)", 
                "safety_issue": "No", 
                "time_frame": "Weeks 12, 48, 96, and 168"
            }, 
            {
                "description": "A blood sample was drawn to determine the amount of HIV-1 RNA virus in copies/mL at Weeks 12, 24, 48, 96, and 168.  Change from Baseline was defined as the HIV-1 RNA level at Weeks 12, 24, 48, 96, and 168 minus the HIV-1 RNA level at Baseline.", 
                "measure": "Median Change From Baseline HIV-1 RNA Values at Weeks 12, 48, 96, and 168 Visits", 
                "safety_issue": "No", 
                "time_frame": "Baseline and Weeks 12, 48, 96, and 168"
            }, 
            {
                "description": "A blood sample was drawn to determine the CD4+ cell count at Weeks 24, 48, 96, and 168. Change from Baseline was defined as the CD4+ cell count at Weeks 24, 48, 96, and 168 minus the CD4+ cell count at Baseline.", 
                "measure": "Median Change From Baseline in CD4+ Values at Week 12, 48, 96, and 168 Visits", 
                "safety_issue": "No", 
                "time_frame": "Baseline and Weeks 12, 48, 96, and 168"
            }, 
            {
                "description": "A blood sample was drawn for participants failing to respond to therapy, and the mutations present in the virus were identified.  For each participant, the mutations found at the time of failure were compared with any mutations found in the blood sample at baseline.  New mutations that developed at the time of virologic failure were tabulated by drug class. Virologic failure is defined as HIV-1 RNA greater than or equal to 400 copies/mL.", 
                "measure": "Number of Participants With APV Resistance Associated HIV-1 RNA Genotypic Mutations and Phenotypic Resistance at Time of Virologic Failure Not Present at Baseline", 
                "safety_issue": "No", 
                "time_frame": "Time of virologic failure"
            }
        ], 
        "source": "GlaxoSmithKline", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "GlaxoSmithKline", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2002", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2011"
    }, 
    "geocoordinates": {
        "GSK Investigational Site": "39.47 -0.377"
    }
}